2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparibovarian carcinosarcomaRecruitingPhase 2 / Phase 32026-09-09NCT03651206
Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian CancerAdnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorderRecruitingPhase 22026-04-13NCT05183984